Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Procyon Corporation (PCYN)
USD0.17
-0.11 (-39.29%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
1300 South Highland Avenue 33756
Clearwater, FL, US
Clearwater, FL, US
CEO
Justice W. Anderson
Website
procyoncorp.com
IPO
1996-12-11
CIK 812306 ISIN US7428063009
Description
Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States. The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.17
-0.11 (-39.29%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
329
Beta
-1.03
Float Shares
2.85M
Free Float %
35.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +6.91% | +66.12% | +66.12% | +11.67% | -35.99% | -46.11% | +34.00% | -86.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.17
DCF (Unlevered)
0.81
+378.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Quality scores
Altman Z-Score
2.03
Grey zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+33.9% ★ Q2'24: +17.5% (vs Q2'23)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+105.7% ★ Q2'24: +966.7% (vs Q2'23)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-7.3% Q2'24: +0.1% (vs Q2'23)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+0.1% Q2'24: +4.9% (vs Q2'23)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+0.2% Q2'24: +16.3% (vs Q2'23)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+3.9% Q2'24: +0.4% (vs Q2'23)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×0.50× ★ Q2'24: 0.58× (vs Q2'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-80.7K
OE per share TTM
-0.01
Owner's Yield
-4.93%
Maintenance CapEx ratio
78.47%
Maint CapEx / Avg PPE
14.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
4
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 10 | 1.60M | 19.90% | — | 1.60M | — | 1.60M | IN | Florida | 2015-02-26 | ↗ |
| 2 | Lynnda L. Speer | 1.52M | 18.70% | — | 1.52M | — | — | IN | Florida | 2022-01-13 | ↗ |
| 3 | Richard M. Speer | 1.52M | 18.70% | — | 1.52M | — | — | IN | Florida | 2022-01-13 | ↗ |
| 4 | Speer Foundation | 1.52M | 18.70% | — | 1.52M | — | — | OO | Florida | 2022-01-13 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
2
Shares acquired
—
Shares disposed
80.0K
Cash buys
—
Cash sales
2.00
Net activity
-80,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-31 | Treshler Joseph Raymond | Director | A-Award | A | Common Stock | 7,440 | 0.25 | 1.9K | 7,440 | D | ↗ |
| 2024-07-31 | SUGGS FRED WILSON JR | Director | A-Award | A | Stock Options | 12,848 | 0.25 | 3.2K | 12,848 | D | ↗ |
| 2024-07-31 | McCullough Monica | Director | A-Award | A | Common Stock | 7,200 | 0.25 | 1.8K | 7,200 | D | ↗ |
| 2024-07-31 | McComas Steven | Director | A-Award | A | Common Stock | 5,600 | 0.25 | 1.4K | 5,600 | D | ↗ |
| 2024-06-26 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 40,000 | 0.18 | 7.3K | 1,380,000 | — | ↗ |
| 2024-06-25 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 40,000 | 0.19 | 7.6K | 1,420,000 | — | ↗ |
| 2023-07-31 | Treshler Joseph Raymond | Director | A-Award | A | Common Stock | 8,000 | 0.25 | 2.0K | 8,000 | — | ↗ |
| 2023-07-31 | SUGGS FRED WILSON JR | Director | A-Award | A | Stock Option | 25,432 | 0.25 | 6.3K | 25,432 | — | ↗ |
| 2023-07-31 | McCullough Monica | Director | A-Award | A | Common Stock | 7,200 | 0.25 | 1.8K | 7,200 | — | ↗ |
| 2023-07-31 | McComas Steven | Director | A-Award | A | Common Stock | 5,600 | 0.25 | 1.4K | 5,600 | — | ↗ |
| 2022-03-31 | SPEER FOUNDATION | Director | S-Sale | D | Common Stock | 40,000 | 0.38 | 15.1K | 1,460,000 | — | ↗ |
| 2022-02-07 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 15,000 | 0.35 | 5.3K | 1,500,000 | — | ↗ |
| 2021-12-06 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 25,000 | 0.32 | 8.1K | 1,515,000 | — | ↗ |
| 2021-07-17 | McComas Steven | Director | — | D | Series A Cumulative Convertible Preferred Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | ANDERSON JUSTICE WOLFE | Director / Officer / 10% Owner | A-Award | A | Stock Option | 25,000 | 0.37 | 9.3K | 25,000 | — | ↗ |
| 2021-06-30 | ANDERSON JAMES BRIAN | Director / Officer | A-Award | A | Stock Option | 25,000 | 0.37 | 9.3K | 25,000 | — | ↗ |
| 2021-03-22 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 15,000 | 0.60 | 9.0K | 1,540,000 | — | ↗ |
| 2020-10-08 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.22 | 2.2K | 1,555,000 | — | ↗ |
| 2020-09-24 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 5,000 | 0.20 | 1.0K | 1,565,000 | — | ↗ |
| 2020-07-15 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.20 | 4.0K | 1,570,000 | — | ↗ |
| 2020-06-01 | SPEER FOUNDATION | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.24 | 2.4K | 1,590,000 | — | ↗ |
| 2019-07-12 | McCullough Monica | Director | — | D | Series A Cumulative Convertible Preferred Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-03-13 | Treshler Joseph Raymond | Director | P-Purchase | A | Common Shares | 17,000 | 0.16 | 2.7K | 17,000 | — | ↗ |
| 2017-07-01 | SPEER FOUNDATION | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,600,000 | — | ↗ |
| 2017-06-30 | ANDERSON JUSTICE WOLFE | Director / Officer / 10% Owner | A-Award | A | Stock Option | 25,000 | 0.19 | 4.8K | 25,000 | — | ↗ |
| 2016-06-30 | ANDERSON JUSTICE WOLFE | Director / Officer / 10% Owner | A-Award | A | Stock Option | 40,000 | 0.15 | 6.0K | 40,000 | — | ↗ |
| 2015-05-29 | BORAK GEORGE OTIS | Officer | P-Purchase | A | PCYN Common Stock | 5,900 | 0.15 | 885.00 | 100,092 | — | ↗ |
| 2015-05-26 | BORAK GEORGE OTIS | Officer | P-Purchase | A | PCYN Common Stock | 14,092 | 0.13 | 1.8K | 84,092 | — | ↗ |
| 2014-05-21 | BORAK GEORGE OTIS | Officer | P-Purchase | A | Common Stock | 15,000 | 0.17 | 2.6K | 70,000 | — | ↗ |
| 2014-03-07 | SPEER ROY M FOUNDATION | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,600,000 | — | ↗ |
| 2013-12-10 | KUDELKO PAUL EDWARD | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-01-08 | Treshler Joseph Raymond | Director | — | D | Preferred Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-12-14 | BORAK GEORGE OTIS | Officer | — | D | PCYN | 0 | 0.00 | — | 55,000 | — | ↗ |
| 2012-11-27 | ANDERSON JUSTICE WOLFE | Director / Officer | P-Purchase | D | Common stock | 2,000 | 0.15 | 300.00 | 3,425,500 | — | ↗ |
| 2011-10-21 | ANDERSON REGINA WOLFE | Director | P-Purchase | A | Common Shares | 560 | 0.21 | 117.60 | 78,060 | — | ↗ |
| 2011-06-15 | ANDERSON REGINA WOLFE | Director | P-Purchase | A | Common Shares | 5,000 | 0.19 | 950.00 | 77,500 | — | ↗ |
| 2008-12-11 | SLOWGROVE JEFFREY S | Director | S-Sale | D | Common Stock | 70,000 | 0.15 | 10.5K | 526,200 | — | ↗ |
| 2008-12-11 | FOLEY MICHAEL TIMOTHY | Director | P-Purchase | A | Common Stock | 70,000 | 0.15 | 10.5K | 210,000 | — | ↗ |
| 2007-11-27 | SLOWGROVE JEFFREY S | Director | S-Sale | D | Common Stock | 110,000 | 0.45 | 49.5K | 596,200 | — | ↗ |
| 2007-11-27 | FOLEY MICHAEL TIMOTHY | Director | P-Purchase | A | Common stock | 110,000 | 0.45 | 49.5K | 140,000 | — | ↗ |
| 2007-06-12 | FOLEY MICHAEL TIMOTHY | Director | P-Purchase | A | Common stock | 10,000 | 0.45 | 4.5K | 42,945 | — | ↗ |
| 2007-06-11 | FOLEY MICHAEL TIMOTHY | Director | P-Purchase | A | Common stock | 10,000 | 0.45 | 4.5K | 32,945 | — | ↗ |
| 2007-04-12 | JOHN C ANDERSON TRUST | 10% Owner | — | D | Procyon Corporation - Restricted Stock | 0 | 0.00 | — | 3,350,500 | — | ↗ |
| 2007-04-12 | ANDERSON REGINA WOLFE | Director / Officer | J-Other | D | Procyon Corporation | 50,000 | 0.21 | 10.6K | 0 | — | ↗ |
| 2007-04-12 | ANDERSON JUSTICE WOLFE | Director / Officer / 10% Owner | J-Other | A | Procyon Corporation | 3,350,500 | 0.30 | 1.01M | 3,350,500 | — | ↗ |
| 2006-12-31 | FOLEY MICHAEL TIMOTHY | Director | — | I | Common Shares | 0 | 0.00 | — | 945 | — | ↗ |
| 2005-09-21 | ANDERSON REGINA WOLFE | Director / Officer / 10% Owner | — | I | Procyon Corporation | 0 | 0.00 | — | 3,350,500 | — | ↗ |
| 2005-06-28 | ANDERSON JUSTICE WOLFE | Officer | — | D | Procyon Corporation | 0 | 0.00 | — | 73,000 | — | ↗ |
| 2005-06-28 | ANDERSON JAMES BRIAN | Officer | — | D | Procyon Corporation | 0 | 0.00 | — | 81,000 | — | ↗ |
| 2000-11-18 | JOHN C ANDERSON TRUST | 10% Owner | — | D | Options to purchase Procyon Corporation Common Stock | 10,000 | 0.16 | 1.6K | 0 | — | ↗ |
| 2000-11-18 | ANDERSON REGINA WOLFE | Director / Officer / 10% Owner | — | I | Procyon Corporation | 10,000 | 0.16 | 1.6K | 0 | — | ↗ |
| 2000-11-18 | ANDERSON JAMES BRIAN | Officer | — | D | Procyon Corporation | 5,000 | 0.16 | 797.00 | 0 | — | ↗ |
| 1999-12-31 | ANDERSON REGINA WOLFE | Director / Officer / 10% Owner | — | I | Procyon Corporation | 50,000 | 0.21 | 10.6K | 0 | — | ↗ |
| 1999-12-31 | ANDERSON JAMES BRIAN | Officer | — | D | Procyon Corporation | 25,000 | 0.21 | 5.3K | 0 | — | ↗ |
| 1999-12-05 | JOHN C ANDERSON TRUST | 10% Owner | — | D | Options to purchase Procyon Corporation Common Stock | 50,000 | 0.21 | 10.6K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
182.00
Shares Outstanding
8.12M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | Justice W. Anderson, President (AMERX ) CEO & President (Procyon) as of January 2018 | 285.2K | 4.9K | — | — | — | — | 290.1K | 0.00% | ↗ |
| 2 | 2023 | James B. Anderson, Chief Financial Officer (Procyon), Vice President of Operations (AMERX ) | 207.8K | 4.3K | — | — | — | — | 212.0K | 0.00% | ↗ |
| 3 | 2023 | George O Borak, Vice President Of Sales (AMERX ) | 204.0K | 3.0K | — | — | — | — | 207.0K | 0.00% | ↗ |
| 4 | 2022 | Justice W. Anderson, President (AMERX ) CEO & President (Procyon) as of January 2018 | 260.8K | 79.5K | — | — | — | — | 340.3K | 0.00% | ↗ |
| 5 | 2022 | James B. Anderson, Chief Financial Officer (Procyon), Vice President of Operations (AMERX ) | 190.2K | 47.7K | — | — | — | — | 237.9K | 0.00% | ↗ |
| 6 | 2022 | George O Borak, Vice President Of Sales (AMERX ) | 186.6K | 50.9K | — | — | — | — | 237.5K | 0.00% | ↗ |
| 7 | 2021 | Justice W. Anderson, President (AMERX ) CEO & President (Procyon) as of January 2018 | 251.4K | — | — | 9.8K | 26.4K | — | 287.6K | 3.42% | ↗ |
| 8 | 2021 | James B. Anderson, Chief Financial Officer (Procyon), Vice President of Operations (AMERX ) | 183.1K | — | — | 9.8K | 20.9K | — | 213.9K | 4.60% | ↗ |
| 9 | 2021 | George O Borak, Vice President Of Sales (AMERX ) | 178.9K | — | — | — | 12.2K | — | 191.0K | 0.00% | ↗ |
| 10 | 2020 | Justice W. Anderson, President (AMERX ) CEO & President (Procyon) as of January 2018 | 242.1K | — | — | — | 27.5K | — | 269.6K | 0.00% | ↗ |
| 11 | 2020 | George O Borak, Vice President Of Sales (AMERX ) | 172.2K | — | — | — | 19.7K | — | 192.0K | 0.00% | ↗ |
| 12 | 2020 | James B. Anderson, Chief Financial Officer (Procyon), Vice President of Operations (AMERX ) | 166.9K | — | — | — | 15.9K | — | 182.9K | 0.00% | ↗ |
| 13 | 2019 | Justice W. Anderson, President (AMERX ) CEO & President (Procyon) as of January 2018 | 214.0K | — | — | — | 15.5K | — | 229.5K | 0.00% | ↗ |
| 14 | 2019 | George O Borak, Vice Pres. Of Sales (AMERX ) | 160.0K | 5.2K | — | — | 12.4K | — | 177.6K | 0.00% | ↗ |
| 15 | 2019 | George O Borak, Vice President Of Sales (AMERX ) | 160.0K | 5.2K | — | — | 12.4K | — | 177.6K | 0.00% | ↗ |
| 16 | 2019 | James B. Anderson, Chief Financial Officer (Procyon), Vice President of Operations (AMERX ) | 152.9K | — | — | — | 15.5K | — | 168.4K | 0.00% | ↗ |
| 17 | 2019 | James B. Anderson, Chief Financial Officer, Vice Pres. of Operations (AMERX ) | 152.9K | — | — | — | 15.5K | — | 168.4K | 0.00% | ↗ |
| 18 | 2019 | Regina W. Anderson, President, Chief Executive Officer through December 2017 | 70.0K | — | — | — | 5.1K | — | 75.1K | 0.00% | ↗ |
| 19 | 2018 | Justice W. Anderson, President (AMERX ) CEO & President (Procyon) as of January 2018 | 214.0K | — | — | — | 16.0K | — | 230.0K | 0.00% | ↗ |
| 20 | 2018 | George O Borak, Vice Pres. Of Sales (AMERX ) | 162.8K | 7.7K | — | — | 5.3K | — | 175.8K | 0.00% | ↗ |
| 21 | 2018 | James B. Anderson, Chief Financial Officer, Vice Pres. of Operations (AMERX ) | 152.9K | — | — | — | 16.0K | — | 168.9K | 0.00% | ↗ |
| 22 | 2018 | Regina W. Anderson, President, Chief Executive Officer through December 2017 | 127.9K | — | — | — | 6.0K | — | 133.9K | 0.00% | ↗ |
| 23 | 2017 | Justice W. Anderson, President (Amerx ) | 214.0K | 31.0K | — | 4.7K | 15.8K | — | 265.6K | 1.79% | ↗ |
| 24 | 2017 | Justice W. Anderson, President (AMERX ) CEO & President (Procyon) as of January 2018 | 214.0K | 31.0K | — | 4.7K | 15.8K | — | 265.6K | 1.79% | ↗ |
| 25 | 2017 | George O. Borak, Vice Pres. Of Sales (Amerx ) | 150.0K | 23.9K | — | — | 5.3K | — | 179.2K | 0.00% | ↗ |
| 26 | 2017 | George O Borak, Vice Pres. Of Sales (AMERX ) | 150.0K | 23.9K | — | — | 5.3K | — | 179.2K | 0.00% | ↗ |
| 27 | 2017 | James B. Anderson, Chief Financial Officer, Vice Pres. of Operations (AMERX ) | 151.2K | — | — | — | 15.8K | — | 167.1K | 0.00% | ↗ |
| 28 | 2017 | James B. Anderson, Chief Financial Officer, Vice Pres. of Operations (Amerx ) | 151.2K | — | — | — | 15.8K | — | 167.1K | 0.00% | ↗ |
| 29 | 2017 | Regina W. Anderson, President, Chief Executive Officer | 161.8K | — | — | — | 2.9K | — | 164.7K | 0.00% | ↗ |
| 30 | 2017 | Regina W. Anderson, President, Chief Executive Officer through December 2017 | 161.8K | — | — | — | 2.9K | — | 164.7K | 0.00% | ↗ |
| 31 | 2016 | Justice W. Anderson, President (Amerx ) | 214.0K | 40.9K | — | 5.1K | 21.9K | — | 282.0K | 1.82% | ↗ |
| 32 | 2016 | George O. Borak, Vice Pres. Of Sales (Amerx ) | 149.0K | 29.0K | — | — | 7.3K | — | 186.3K | 0.00% | ↗ |
| 33 | 2016 | George O Borak, Vice Pres. Of Sales (Amerx ) | 150.0K | 29.0K | — | — | 7.3K | — | 181.3K | 0.00% | ↗ |
| 34 | 2016 | Regina W. Anderson, President, Chief Executive Officer | 158.8K | — | — | — | 9.8K | — | 168.6K | 0.00% | ↗ |
| 35 | 2016 | James B. Anderson, Chief Financial Officer, Vice Pres. of Operations (Amerx ) | 129.0K | — | — | — | 21.9K | — | 150.9K | 0.00% | ↗ |
| 36 | 2015 | Justice W. Anderson, President (Amerx ) | 214.0K | — | — | — | — | — | 214.0K | 0.00% | ↗ |
| 37 | 2015 | Regina W. Anderson, President, Chief Executive Officer | 158.8K | — | — | — | — | — | 158.8K | 0.00% | ↗ |
| 38 | 2015 | George O Borak, Vice Pres. Of Sales (Amerx ) | 148.3K | 3.3K | — | — | — | — | 151.6K | 0.00% | ↗ |
| 39 | 2015 | George O Borak, Vice President Of Sales (Amerx ) | 148.3K | — | — | — | — | — | 148.3K | 0.00% | ↗ |
| 40 | 2015 | James B. Anderson, Chief Financial Officer, Vice President of Operations (Amerx) | 122.3K | 2.6K | — | — | — | — | 125.0K | 0.00% | ↗ |
| 41 | 2015 | James B. Anderson, Chief Financial Officer, Vice Pres. of Operations (Amerx ) | 122.3K | — | — | — | — | — | 122.3K | 0.00% | ↗ |
| 42 | 2014 | Justice W. Anderson, President (Amerx ) | 212.0K | 6.6K | — | — | — | — | 218.6K | 0.00% | ↗ |
| 43 | 2014 | Regina W. Anderson, President, Chief Executive Officer | 158.8K | 3.3K | — | — | — | — | 162.1K | 0.00% | ↗ |
| 44 | 2014 | George O Borak, Vice President Of Sales (Amerx ) | 148.8K | — | — | — | — | — | 148.8K | 0.00% | ↗ |
| 45 | 2014 | James B. Anderson, Chief Financial Officer, Vice President of Operations (Amerx) | 120.0K | 11.1K | — | — | — | — | 131.1K | 0.00% | ↗ |
| 46 | 2014 | James B. Anderson, Chief Financial Officer, Vice President of Operations (Amerx ) | 120.0K | 11.1K | — | — | — | — | 131.1K | 0.00% | ↗ |
| 47 | 2013 | Justice W. Anderson, President (Amerx ) | 181.7K | — | — | — | — | 27.9K | 209.6K | 0.00% | ↗ |
| 48 | 2013 | Justice W. Anderson, President (Amerx) | 181.7K | — | — | — | — | 27.9K | 209.6K | 0.00% | ↗ |
| 49 | 2013 | Regina W. Anderson, President, Chief Executive | 158.8K | — | — | — | — | — | 158.8K | 0.00% | ↗ |
| 50 | 2013 | Regina W. Anderson, President, Chief Executive Officer | 158.8K | — | — | — | — | — | 158.8K | 0.00% | ↗ |
| 51 | 2013 | Health Care Corp.) George O. Borak, Vice Pres. Of Sales (Amerx) | 143.2K | — | — | — | — | — | 143.2K | 0.00% | ↗ |
| 52 | 2013 | George O Borak, Vice President Of Sales (Amerx ) | 143.2K | — | — | — | — | — | 143.2K | 0.00% | ↗ |
| 53 | 2013 | James B. Anderson, Chief Financial Officer, Vice President of Operations (Amerx ) | 118.8K | — | — | — | 3.3K | — | 122.0K | 0.00% | ↗ |
| 54 | 2013 | James B. Anderson, Chief Financial, Vice Pres. of Operations (Amerx | 118.8K | — | — | — | 3.3K | — | 122.0K | 0.00% | ↗ |
| 55 | 2012 | Justice W. Anderson, President (Amerx Health Care Corp.) | 40.4K | — | — | — | — | 160.3K | 200.7K | 0.00% | ↗ |
| 56 | 2012 | Justice W. Anderson, President (Amerx) | 40.4K | — | — | — | — | 160.3K | 200.7K | 0.00% | ↗ |
| 57 | 2012 | Regina W. Anderson, President, Chief Executive Officer | 158.8K | — | — | — | — | — | 158.8K | 0.00% | ↗ |
| 58 | 2012 | Regina W. Anderson, President, Chief Executive | 158.8K | — | — | — | — | — | 158.8K | 0.00% | ↗ |
| 59 | 2012 | James B. Anderson, Chief Financial, Vice Pres. of Operations (Amerx | 115.0K | 5.0K | — | — | — | — | 120.0K | 0.00% | ↗ |
| 60 | 2012 | James B. Anderson, Chief Financial Officer, V.P. of Operations Amerx Health Care Corp.) | 115.0K | 5.0K | — | — | — | — | 120.0K | 0.00% | ↗ |
| 61 | 2011 | Justice W. Anderson, President (Amerx Health | 40.4K | — | — | — | — | 154.2K | 194.6K | 0.00% | ↗ |
| 62 | 2011 | Justice W. Anderson, President (Amerx Health Care Corp.) | 40.4K | — | — | — | — | 154.2K | 194.6K | 0.00% | ↗ |
| 63 | 2011 | Regina W. Anderson, President, Chief Executive Officer | 158.8K | — | — | — | — | — | 158.8K | 0.00% | ↗ |
| 64 | 2011 | Care Corp.) James B. Anderson, Chief Financial Officer, V.P. of Operations (Amerx | 101.7K | — | — | — | — | — | 101.7K | 0.00% | ↗ |
| 65 | 2011 | James B. Anderson, Chief Financial Officer, V.P. of Operations Amerx Health Care Corp.) | 101.7K | — | — | — | — | — | 101.7K | 0.00% | ↗ |
| 66 | 2010 | Justice W. Anderson, President (Amerx Health Care Corp.) | 40.4K | — | — | — | — | — | 186.4K | 0.00% | ↗ |
| 67 | 2010 | Justice W. Anderson, President (Amerx Health | 40.4K | — | — | — | — | 146.0K | 186.4K | 0.00% | ↗ |
| 68 | 2010 | Regina W. Anderson, President, Chief Executive Officer | 158.8K | — | — | — | — | — | 158.8K | 0.00% | ↗ |
| 69 | 2010 | James B. Anderson, Chief Financial Officer, V.P. of Operations (Amerx | 99.0K | — | — | — | — | — | 99.0K | 0.00% | ↗ |
| 70 | 2010 | Care Corp.) James B. Anderson, Chief Financial Officer, V.P. of Operations (Amerx | 99.0K | — | — | — | — | — | 99.0K | 0.00% | ↗ |
| 71 | 2009 | Justice W. Anderson, President (Amerx Health Care Corp.) | 40.4K | 2.3K | — | — | — | — | 159.5K | 0.00% | ↗ |
| 72 | 2009 | Regina W. Anderson, President, Chief Executive Officer | 152.2K | 2.0K | — | — | — | — | 154.2K | 0.00% | ↗ |
| 73 | 2009 | James B. Anderson, Chief Financial Officer, V.P. of Operations (Amerx | 99.0K | 2.3K | — | — | — | — | 101.2K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Justice W. Anderson | Chief Executive Officer, President & Director | 291.4K | male |
| James Anderson | Chief Financial Officer & Director | 215.4K | male |
| George Otis Borak | Vice President of Sales - Amerx Health Care Corporation | 206.4K | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PCYN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
